Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4-Reference-Cited by-同舟云学术

Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4

Published:2022-06-10 Issue:3 Volume:112 Page:527-539
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Hafey Michael J.¹,Aleksunes Lauren M.²,Bridges Christy C.³,Brouwer Kenneth R.⁴,Chien Huan‐Chieh⁵,Leslie Elaine M.⁶,Hu Shuiying⁷,Li Yang⁸,Shen Jinshan⁹,Sparreboom Alex⁸,Sprowl Jason¹⁰,Tweedie Donald¹¹,Lai Yurong¹²

Affiliation:

1. ADME and Discovery Toxicology Merck & Co., Inc. Rahway New Jersey USA

2. Department of Pharmacology and Toxicology Rutgers University Piscataway New Jersey USA

3. Department of Biomedical Sciences Mercer University School of Medicine Macon Georgia USA

4. ADME‐Tox BioIVT Durham North Carolina USA

5. Pharmacokinetics and Drug Metabolism Amgen, Inc. South San Francisco California USA

6. Departments of Physiology and Lab Med and Path Membrane Protein Disease Research Group University of Alberta Edmonton Alberta Canada

7. Division of Outcomes and Translational Sciences College of Pharmacy The Ohio State University Columbus Ohio USA

8. Division of Pharmaceutics and Pharmacology College of Pharmacy The Ohio State University Columbus Ohio USA

9. Relay Therapeutics Cambridge Massachusetts USA

10. Department of Pharmaceutical Sciences School of Pharmacy and Pharmaceutical Sciences University at Buffalo Buffalo New York USA

11. Independent Consultant Madison Connecticut USA

12. Drug Metabolism Gilead Sciences Inc. Foster City California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2638

Reference142 articles.

1. Membrane transporters in drug development

2. Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium

3. Transporter Studies in Drug Development: Experience to Date and Follow-Up on Decision Trees From the International Transporter Consortium

4. Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance

5. Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of efflux transporters in cytotoxicity and intracellular concentration of chlorpyrifos and chlorpyrifos oxon in human cell lines;Toxicology in Vitro;2024-09

2. Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier;Drug Metabolism Reviews;2024-07-05

3. Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors;Chemosphere;2024-06

4. Transcending Molecules: Paving the Way from Lab to Life in Drug Transport Innovation;Current Drug Targets;2024-05

5. Darolutamide does not interfere with OATP‐mediated uptake of docetaxel;International Journal of Cancer;2024-03-16